|
|
Article: Center for Molecular Medicine First Midwest-Based Lab Offering Roche Test to Help Predict Drug Performance & Improve Safety.
- Article from:
- PR Newswire
- Article date:
- June 13, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GRAND RAPIDS, Mich., June 13 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced it is the first Midwest-based laboratory to offer the FDA-approved AmpliChip(R) CYP450 Test to physicians and hospitals.
This genomics-based, FDA-approved clinical laboratory test provides physicians information that may be used to help determine a patient's unique ability or inability to metabolize a large variety of prescription drugs. AmpliChip CYP450 test results may be used by physicians to make more rational drug prescription decisions, reduce "trial and error" prescription and dosing and guard against dangerous and expensive adverse drug reactions.
Related newspaper, magazine, and journal articles:
|
|
Article: Center for Molecular Medicine Among First Labs in ...
PR Newswire;
December 12, 2007 ;
700+ words
...GRAND RAPIDS, Mich., Dec ... The Center for Molecular Medicine (CMM) today ... expanding field of molecular medicine." The CellSearch ... The Center for Molecular Medicine, a joint venture between Grand Rapids, Mich.-based ...
|
|